Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2016, Article ID 5473681, 7 pages
http://dx.doi.org/10.1155/2016/5473681
Research Article

Precancerous Cervix in Human Immunodeficiency Virus Infected Women Thirty Years Old and above in Northern Uganda

1Institute of Public Health and Management, International Health Sciences University, P.O. Box 7782, Kampala, Uganda
2Uganda Society for Health Scientists, Department of Anatomy, Makerere University College of Health Sciences, P.O. Box 7072, Kampala, Uganda
3The AIDS Support Organization, TASO Gulu, P.O. Box 347, Gulu, Uganda
4Department of Gynecology and Obstetrics, College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda

Received 25 January 2016; Revised 6 June 2016; Accepted 14 June 2016

Academic Editor: Peter E. Schwartz

Copyright © 2016 Jonathan Izudi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. L. Franco and A. Ferenczy, “Cervix,” in Cancer Precursors, pp. 249–286, Springer, Berlin, Germany, 2002. View at Google Scholar
  2. HealthLine Cervical dysplasia, http://umm.edu/health/medical/altmed/condition/cervical-dysplasia.
  3. World Health Organization, “Cancer,” Fact Sheet N° 297, World Health Organization Media Center, Geneva, Switzerland, 2015, http://www.who.int/mediacentre/factsheets/fs297/en/. View at Google Scholar
  4. WHO media center, http://www.who.int/mediacentre/factsheets/fs297/en/.
  5. U. Ononogbu, M. Almujtaba, F. Modibbo et al., “Cervical cancer risk factors among HIV-infected Nigerian women,” BMC Public Health, vol. 13, no. 1, pp. 1471–2458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. World Health Organization, WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention: Supplemental Material: GRADE Evidence-to-Recommendation Tables and Evidence Profiles for Each Recommendation, WHO, 2013.
  7. N. S. Murthy and A. Mathew, “Risk factors for pre-cancerous lesions of the cervix,” European Journal of Cancer Prevention, vol. 9, no. 1, pp. 5–14, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. P. K. S. Chan, W.-H. Li, M. Y. M. Chan, W.-L. Ma, J. L. K. Cheung, and A. F. Cheng, “High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions,” Journal of Medical Virology, vol. 59, no. 2, pp. 232–238, 1999. View at Google Scholar · View at Scopus
  9. H. J. An, N. H. Cho, S. Y. Lee et al., “Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method,” Cancer, vol. 97, no. 7, pp. 1672–1680, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Memiah, W. Mbuthia, G. Kiiru et al., “Prevalence and risk factors associated with precancerous cervical cancer lesions among HIV-infected women in resource-limited settings,” AIDS Research and Treatment, vol. 2012, Article ID 953743, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. R. Melamed and B. J. Flehinger, “Early incidence rates of precancerous cervical lesions in women using contraceptives,” Gynecologic Oncology, vol. 1, no. 4, pp. 290–298, 1973. View at Publisher · View at Google Scholar · View at Scopus
  12. S. A. Cannistra and J. M. Niloff, “Cancer of the uterine cervix,” The New England Journal of Medicine, vol. 334, no. 16, pp. 1030–1038, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. TASO Gulu, http://www.tasouganda.org/index.php/component/content/article?id=79.
  14. K. Mugabe, Prevalence and factors associated with precancerous cervical lesions among HIV positive women attending Mulago Hospital, Uganda [M.S. thesis], Makerere University, 2013.
  15. A. Gedefaw, A. Astatkie, and G. A. Tessema, “The prevalence of precancerous cervical cancer lesion among HIV-infected women in Southern Ethiopia: a cross-sectional study,” PLoS ONE, vol. 8, no. 12, Article ID e84519, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. P. E. Castle, B. Fetterman, J. Thomas Cox et al., “The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer,” Obstetrics & Gynecology, vol. 116, no. 1, pp. 76–84, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Fatiregun, I. Yisa, and E. Bamgboye, “Risk factors for cancer of the cervix,” The Nigerian Postgraduate Medical Journal, vol. 14, no. 1, pp. 46–49, 2007. View at Google Scholar
  18. F. X. Bosch, N. Munoz, S. De Sanjosé et al., “Risk factors for cervical cancer in Colombia and Spain,” International Journal of Cancer, vol. 52, no. 5, pp. 750–758, 1992. View at Publisher · View at Google Scholar · View at Scopus
  19. Cervical cancer, http://www.cancer.ca/en/cancer-information/cancer-type/cervical/risks/?region=bc.
  20. Cervical cancer in-depth report, http://www.nytimes.com/health/guides/disease/cervical-cancer/print.html.
  21. K. O. Ngwogu, G. Ndubuka, and A. C. Ngwogu, “Prevalence of squamous cell carcinoma among cervical cancer patients in Igbos of Nigeria,” International Journal of Community Research, vol. 3, no. 2, pp. 49–54, 2014. View at Google Scholar
  22. A. A. Fatiregun, I. O. Yisa, and E. A. Bamgboye, “Risk factors for cancer of the cervix,” Nigerian Postgraduate Medical Journal, vol. 14, no. 1, pp. 46–49, 2007. View at Google Scholar